Correlation Between Aarey Drugs and Paramount Communications

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aarey Drugs and Paramount Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aarey Drugs and Paramount Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aarey Drugs Pharmaceuticals and Paramount Communications Limited, you can compare the effects of market volatilities on Aarey Drugs and Paramount Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aarey Drugs with a short position of Paramount Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aarey Drugs and Paramount Communications.

Diversification Opportunities for Aarey Drugs and Paramount Communications

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Aarey and Paramount is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Aarey Drugs Pharmaceuticals and Paramount Communications Limit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paramount Communications and Aarey Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aarey Drugs Pharmaceuticals are associated (or correlated) with Paramount Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paramount Communications has no effect on the direction of Aarey Drugs i.e., Aarey Drugs and Paramount Communications go up and down completely randomly.

Pair Corralation between Aarey Drugs and Paramount Communications

Assuming the 90 days trading horizon Aarey Drugs Pharmaceuticals is expected to under-perform the Paramount Communications. In addition to that, Aarey Drugs is 1.22 times more volatile than Paramount Communications Limited. It trades about -0.05 of its total potential returns per unit of risk. Paramount Communications Limited is currently generating about -0.02 per unit of volatility. If you would invest  6,781  in Paramount Communications Limited on August 26, 2024 and sell it today you would lose (100.00) from holding Paramount Communications Limited or give up 1.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Aarey Drugs Pharmaceuticals  vs.  Paramount Communications Limit

 Performance 
       Timeline  
Aarey Drugs Pharmace 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Paramount Communications 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Paramount Communications Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Aarey Drugs and Paramount Communications Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aarey Drugs and Paramount Communications

The main advantage of trading using opposite Aarey Drugs and Paramount Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aarey Drugs position performs unexpectedly, Paramount Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paramount Communications will offset losses from the drop in Paramount Communications' long position.
The idea behind Aarey Drugs Pharmaceuticals and Paramount Communications Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity